Panzyga 100 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

panzyga 100 mg/ml inf. sol. i.v. vial

octapharma benelux sa-nv - human normal immunoglobulin 100 mg/ml - solution for infusion - 100 mg/ml - human polyvalent immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.

Panzyga 100 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

panzyga 100 mg/ml inf. sol. i.v. vial

octapharma benelux sa-nv - human normal immunoglobulin 100 mg/ml - solution for infusion - 100 mg/ml - human polyvalent immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.

Panzyga 100 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

panzyga 100 mg/ml inf. sol. i.v. vial

octapharma benelux sa-nv - human normal immunoglobulin 100 mg/ml - solution for infusion - 100 mg/ml - human polyvalent immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.

Panzyga 100 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

panzyga 100 mg/ml inf. sol. i.v. vial

octapharma benelux sa-nv - human normal immunoglobulin 100 mg/ml - solution for infusion - 100 mg/ml - human polyvalent immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.

Panzyga 100 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

panzyga 100 mg/ml inf. sol. i.v. vial

octapharma benelux sa-nv - human normal immunoglobulin 100 mg/ml - solution for infusion - 100 mg/ml - human polyvalent immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.

Panzyga Solution for Infusion 100mg/ml Malta - English - Medicines Authority

panzyga solution for infusion 100mg/ml

octapharma (ip) limited - human normal immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg/ml - immune sera and immunoglobulins

PANZYGA 100 Mg/Ml Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

panzyga 100 mg/ml solution for infusion

octapharma limited - human normal immunoglobulin - solution for infusion - 100 mg/ml - immunoglobulins, normal human

Panzyga 100mg/ml solution for infusion (20g/20ml) Malta - English - Medicines Authority

panzyga 100mg/ml solution for infusion (20g/20ml)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 100 mmol/ml - immune sera and immunoglobulins

Flebogamma 10% DIF New Zealand - English - Medsafe (Medicines Safety Authority)

flebogamma 10% dif

pharmaco (nz) ltd - normal immunoglobulin 100 mg/ml - solution for infusion - 100 g/l - active: normal immunoglobulin 100 mg/ml excipient: sorbitol water for injection - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation indications: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count. - guillan barre syndrome. - kawasaki disease.

FLEBOGAMMA 5% DIF Human normal immunoglobulin 20g/400mL intravenous use injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

flebogamma 5% dif human normal immunoglobulin 20g/400ml intravenous use injection vial

grifols australia pty ltd - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: human immunoglobulin a; water for injections; sorbitol - replacement therapy in: primary immunodeficiency syndromes such as: congenital agammaglobulinaemia and hypogammaglobulinaemia, common variable immunodeficiency, severe combined immunodeficiency, wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; and children with congenital aids and recurrent infections. immunomodulation: idiopathic thrombocytopenia purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, guillian barre syndrome. allogenic bone marrow transplantation.